-
Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025
13 May 2025 11:11 GMT
… Oral abstract session: Lung cancer—non-small cell metastatic
… , Oral abstract session: Lung cancer—non-small cell metastatic
… carboplatin and either paclitaxel or paclitaxel protein-bound, is … carboplatin and either paclitaxel or paclitaxel protein-bound in …
-
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2025
12 May 2025 12:00 GMT
… extensive stage Small Cell Lung Cancer
First cohort dosed in … With Extensive-Stage Small Cell Lung Cancer”, will evaluate the safety … tumors such as small cell lung cancer (SCLC), neuroendocrine tumors (NET … (FCCC) in combination with paclitaxel in R/R …
-
Switching From Avastin to Bevacizumab-bvzr in CRC, NSCLC Can Reduce Medicare Costs
10 May 2025 19:56 GMT
… metastatic non-small cell lung cancer (mNSCLC) from the … combination with carboplatin and paclitaxel. According to the authors … patients with bevacizumab-bvzr + paclitaxel + carboplatin was 43.
Bevacizumab … squamous non-small cell lung cancer in Medicare. J …
-
US FDA approves Verastem's Avmapki Fakzynja combo therapy to treat patients with KRAS─mutated recurrent low─grade serous ovarian cancer
10 May 2025 07:51 GMT
… G12C mutant non-small cell lung cancer (NSCLC) who have not been … defactinib with gemcitabine/nab-paclitaxel in patients with front-line …
-
FDA Grants First-Ever Approval for KRAS-Mutated Recurrent Ovarian Cancer Treatment
09 May 2025 21:06 GMT
… G12C mutant non-small cell lung cancer (NSCLC) who have not been … defactinib with gemcitabine/nab-paclitaxel in patients with front-line …
-
IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial
09 May 2025 11:20 GMT
… IMFINZI with Carboplatin and Paclitaxel
Immune-mediated hypothyroidism occurred … -stage Small Cell Lung Cancer
In patients with limited … Extensive-stage Small Cell Lung Cancer
In patients with extensive … extensive-stage small cell lung cancer (ES-SCLC).
IMFINZI, …
-
Cancer Patients’ Behavior and Perception on the Use of Medical Foods and Dietary Supplements During Chemotherapy
09 May 2025 10:21 GMT
… alone, carboplatin alone or with paclitaxel, gemcitabine, pemetrexed, or etoposide), … taxane-based regimens (paclitaxel alone or with trastuzumab, docetaxel … intakes in non-small cell lung cancer patients receiving chemotherapy. Thai JPEN …
-
FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated Recurrent Low-Grade Serous Ovarian Cancer
08 May 2025 17:36 GMT
… G12C mutant non-small cell lung cancer (NSCLC) who have not been … defactinib with gemcitabine/nab-paclitaxel in patients with front-line …
-
ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
08 May 2025 12:00 GMT
… tumors such as small cell lung cancer (SCLC), neuroendocrine tumors (NET), medulloblastoma … Center (FCCC) in combination with paclitaxel in R/R neuroendocrine …
-
Enhertu followed by THP before surgery showed statistically significant and clinically meaningful improvement in pCR in patients with high─risk HER2─positive early─stage breast cancer in DESTINY─Breast11 phase III trial
08 May 2025 07:10 GMT
… Enhertu (trastuzumab deruxtecan) followed by paclitaxel, trastuzumab and pertuzumab (THP) demonstrated … or metastatic non-small cell lung cancer (NSCLC) whose tumours have activating …
About
© 1995-2025